Last $3.03 USD
Change Today +0.05 / 1.68%
Volume 84.6K
FCSC On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 12:00 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David M. Pernock

Chairman, Chief Executive Officer and President, Fibrocell Science, Inc.
AgeTotal Calculated CompensationThis person is connected to 83 board members in 4 different organizations across 2 different industries.

See Board Relationships
59$2,799,181
As of Fiscal Year 2013

Background*

Mr. David M. Pernock has been the Chairman and Chief Executive Officer of Fibrocell Science, Inc. since September 2009 and February 1, 2010 respectively and also serves as its President. Mr. Pernock served as the Senior Vice President of U.S., pharmaceuticals/vaccines & Biologics, Specialty Businesses - Philadelphia for GlaxoSmithKline P.L.C. He served in a variety of executive capacities for GlaxoSmithKline (GSK) from 1994 to 2009. Mr. Pernock has been a Director of ...

Read Full Background

Corporate Headquarters*

405 Eagleview Boulevard
Exton, Pennsylvania 19341

United States

Phone: 484-713-6000
Fax: --

Board Members Memberships*

Director
2009-N/A
Former Director
2009-Present
Chairman, Chief Executive Officer and President
2013-Present
Director

Education*

BSBA
Arizona State University-Tempe

Other Affiliations*

Annual Compensation*

Salary$454,769
Total Annual Compensation$454,769

Stock Options*

Exercisable Options271,750
Unexercisable Options931,250
Unexercisable Options Value$528,000
Total Value of Options$528,000
Total Number of Options1,203,000

Total Compensation*

Total Annual Cash Compensation$454,769
Total Short Term Compensation$454,769
Total Calculated Compensation$2,799,181
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FCSC:US $3.03 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
$392.5K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Edward O. Lanphier IIFounder, Chief Executive Officer, President, Director and Member of Clinical Review Committee
Sangamo Biosciences Inc.
$640.0K
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$362.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIBROCELL SCIENCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.